SUBSCRIBE
SUBSCRIBE

Dynavax Technologies

NEWS
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
Drug Development
FDA Panel Votes to Recommend Dynavax’s Hepatitis B Vaccine; Hepsilav Can Compete With GlaxoSmithKline’s Engerix-B
July 31, 2017
 · 
2 min read
Bay Area's Dynavax Quietly Shops Around Its Almost-Approved Hep B Vaccine
Drug Development
Death Count Rises for Patients on Dynavax’s Hep B Vaccine But Overall Rate Was Low, Says the FDA
July 26, 2017
 · 
2 min read
Bay Area's Dynavax Quietly Shops Around Its Almost-Approved Hep B Vaccine
Job Trends
Bay Area’s Dynavax Shifts Focus to Immune-Oncology, Cuts 40% of Staff
March 13, 2017
 · 
3 min read
Biotech Bay
Dynavax In 2017: Hero Or Zero?
January 19, 2017
 · 
1 min read
Bay Area's Depomed Craters as New CEO, Directors are Named in Deal with Activist Investor
Job Trends
Bay Area’s Dynavax Slashes Global Workforce by 38% in Restructuring
January 5, 2017
 · 
3 min read
Antares Pharma Implodes After FDA Responds to Its Xyosted NDA
FDA
Bay Area’s Dynavax Plunges After the FDA Spurns HEPLISAV-B Again
November 14, 2016
 · 
2 min read
Biotech Bay
Bay Area’s Dynavax Could Need a Plan B if Heplisav-B is Rejected in December
October 17, 2016
 · 
1 min read
Top 5 Bay Area Biomed Hot Spots
Job Trends
Top 5 Bay Area Biomed Hot Spots
June 20, 2016
 · 
5 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Bay
In a Volatile Biotech Market, Here are 3 Stocks To Consider
April 12, 2016
 · 
3 min read
Load More
JOBS
IN THE PRESS
Press Releases
Dynavax Advances Board Refreshment Program
January 28, 2025
 · 
8 min read
Press Releases
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights
January 13, 2025
 · 
8 min read
Press Releases
Dynavax Announces $200 Million Share Repurchase Program
November 8, 2024
 · 
4 min read
Press Releases
Dynavax Adopts Limited-Duration Stockholder Rights Plan
October 30, 2024
 · 
5 min read
Business
Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
October 24, 2024
 · 
1 min read
Biotech Bay
Dynavax to Present at Upcoming June 2024 Investor Conferences
May 28, 2024
 · 
1 min read
Biotech Bay
Dynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B® Regimen for Adults on Hemodialysis in the U.S.
May 14, 2024
 · 
5 min read
Business
Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates
May 8, 2024
 · 
13 min read
Business
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
January 8, 2024
 · 
9 min read
Biotech Bay
Dynavax to Present at Upcoming June 2023 Investor Conferences
May 30, 2023
 · 
1 min read
Load More